Jonathan Siegal
Comptroller/Controller/Auditor presso VERICEL CORPORATION
Patrimonio netto: 63 630 $ in data 30/04/2024
Profilo
Jonathan D.
Siegal is currently working as the Chief Accounting Officer, VP & Controller at Vericel Corp.
Prior to his current position, he worked as the Global Controller at Lantheus Medical Imaging, Inc. from 2016 to 2021.
Mr. Siegal completed his undergraduate degree at Gordon College.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
VERICEL CORPORATION
0.00% | 07/03/2024 | 1 400 ( 0.00% ) | 63 630 $ | 30/04/2024 |
Posizioni attive di Jonathan Siegal
Società | Posizione | Inizio |
---|---|---|
VERICEL CORPORATION | Comptroller/Controller/Auditor | - |
Precedenti posizioni note di Jonathan Siegal
Società | Posizione | Fine |
---|---|---|
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Comptroller/Controller/Auditor | 01/01/2021 |
Formazione di Jonathan Siegal
Gordon College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
VERICEL CORPORATION | Health Technology |
Aziende private | 1 |
---|---|
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |
- Borsa valori
- Insiders
- Jonathan Siegal